Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £49.48m
CASP Live PriceLast checked at - London Stock Exchange

Intraday Caspian Sunrise Share Chart

Issue of Equity and Option Awards

24 Apr 2024 07:00

RNS Number : 7640L
Caspian Sunrise plc
24 April 2024
Β 

Β 

Caspian Sunrise PLC

Β 

("Caspian Sunrise", or the "Company")

Β 

Issue of Equity and Option Awards

Β 

Β 

Equity issue

Β 

Caspian Sunrise announces the issue of 4,476,923 new ordinary shares of 1 pence each in the Company at 3.25 pence per share ("New Shares") in settlement of certain outstanding fees owed to an adviser.

Β 

Application will be made for the New Shares to be admitted to trading on AIM, which is expected to occur on or around 29 April 2024 ("Admission"). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares currently traded on AIM.

Β 

Following Admission, the Company's issued share capital will comprise 2,254,978,483 ordinary shares of 1 pence each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Β 

Option grants

Β 

The Company has awarded in total 4,500,000 new options, including 2,500,000 4p options to Seokwoo Shin, a director of the Company, with the additional 2,000,000 options being issued non board staff. 2,500,000 5.5p options previously awarded to Seokwoo Shin have been cancelled, resulting in the net new options totalling 2,000,000.

Β 

Additionally, the exercise date for 2,400,000 4p options held by Clive Carver has been extended until 30 April 2025.

Β 

In total there are now 16,850,000 outstanding options representing approximately 0.75% of the Company's current issued share capital.

Β 

Β 

Caspian Sunrise PLC

Β 

Clive Carver, Chairman +7 727 375 0202

Β 

WH Ireland, Nominated Adviser & Broker

Β 

James Joyce +44 (0) 207 220 1666

James Bavister

Andrew de Andrade

Β 

Β 

This announcement has been posted to:

www.caspiansunrise.com/investors

Β 

Β 

1

Details of the person discharging managerial responsibilities

a)

Name

Seokwoo Shin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Caspian Sunrise plc

b)

LEI

213800ODCON58VWIRS18

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ordinary shares of 0.001p each

Β 

GB00B1W0VW36

b)

Nature of the transaction

Options issued

c)

Price(s) and volume(s)

Price(s)

Volume(s)

4p

Β 

2,500,000

Β 

d)

Aggregated information

- Aggregated volume

Β - Price

Β 

2,500,000

4p

e)

Date of the transaction

23 April 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Details of the person discharging managerial responsibilities

a)

Name

Clive Carver

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Caspian Sunrise plc

b)

LEI

213800ODCON58VWIRS18

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ordinary shares of 0.001p each

Β 

GB00B1W0VW36

b)

Nature of the transaction

Options extension

c)

Price(s) and volume(s)

Price(s)

Volume(s)

4p

Β 

2,400,000

Β 

d)

Aggregated information

- Aggregated volume

Β - Price

Β 

2,400,000

4p

e)

Date of the transaction

23 April 2024

f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEQKNBBOBKDFQB
Date   Source Headline
18th May 20269:00 amRNSUpdate
23rd Mar 20267:00 amRNSAcquisition of Mineral Assets
13th Mar 20267:33 amRNSUpdate
13th Mar 20267:33 amRNSUpdate
3rd Mar 202611:07 amRNSFirst oil from the West Shalva Contract Area
10th Feb 20267:00 amRNSTesting at the West Shalva Contract Area
2nd Feb 20267:00 amRNSGeneral Meeting Results
28th Jan 20267:00 amRNSCompletion of the acquisition of the Block 8
7th Jan 20267:00 amRNSNotice of GM
30th Dec 20257:00 amRNSRe-issue of BNG Contract Area licences
30th Dec 20257:00 amRNSRe-issue of BNG Contract Area licences
22nd Dec 202511:15 amRNSReplacement: Acquisition of Tau-Cen
22nd Dec 202511:15 amRNSReplacement: Acquisition of Tau-Cen
22nd Dec 20257:00 amRNSAcquisition of Tau-Cen
22nd Dec 20257:00 amRNSAcquisition of Tau-Cen
4th Dec 20251:00 pmRNSPosting of Annual Report & Accounts
4th Dec 20258:32 amRNSExemption from future Historic Costs at the BNG
3rd Dec 20257:00 amRNSAward of licence at the BNG Contract Area
2nd Dec 20257:00 amRNSIssue of shares
1st Dec 20258:55 amRNSReplacement 2025 Interim Results
1st Dec 20257:30 amRNSRestoration - Caspian Sunrise Plc
1st Dec 20257:07 amRNSInterim results for six months ended 30 June 2025
1st Dec 20257:00 amRNSAnnual report for the year ended 31 December 2024
31st Oct 20257:00 amRNSGeneral update
3rd Oct 20257:00 amRNSFirst well spudded at West Shalva Contract Area
30th Sep 20254:01 pmRNSDelay to the publication of results
27th Aug 20258:43 amRNSCorporate update
26th Aug 20256:00 pmRNSSuspended Companies Notice - Deletion
23rd Jul 20258:36 amRNSUpdate regarding the sale of MJF & South Yelemes
11th Jul 20259:23 amRNSUpdate on Block 8 Well Tests
9th Jul 20257:00 amRNSUpdate regarding sale of MJF and South Yelemes
1st Jul 20257:30 amRNSSuspension - Caspian Sunrise PLC
25th Jun 202512:57 pmRNSResult of AGM and matters discussed
18th Jun 20257:00 amRNSProduction and Testing from Block 8 Contract Area
16th Jun 20257:00 amRNSGeneral Update
30th May 20257:00 amRNSNotice of AGM
23rd May 20251:21 pmRNSAward of production licence at BNG Contract Area
1st May 20257:35 amRNSCorporate Update
15th Apr 202510:20 amRNSCompletion of West Shalva acquisition
1st Apr 20257:00 amRNSUpdate on the disposal of MJF & South Yelemes
3rd Mar 20257:00 amRNSCorporate & Operational update
26th Feb 20257:00 amRNSBNG deep structures conditional funding
21st Feb 20257:00 amRNSWest Shalva update
2nd Jan 20257:00 amRNSUpdate on the disposal of MJF & South Yelemes
21st Nov 202412:43 pmRNSDisposal of the BNG shallow MJF & South Yelemes
5th Nov 20247:00 amRNSUpdate on acquisition of West Shalva Contract Area
31st Oct 20247:00 amRNSUpdate on the disposal of MJF & South Yelemes
26th Sep 202412:59 pmRNSGeneral Meeting Results
25th Sep 20247:00 amRNSInterim results for six months ended 30 June 2024
4th Sep 20247:00 amRNSDisposal of the shallow MJF & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.